Oslo - Delayed Quote NOK
Lytix Biopharma AS (LYTIX.OL)
5.26
-0.12
(-2.23%)
As of 1:07:43 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 1.7M | 90.3M |
| Low Estimate | -- | -- | 1.7M | 90.3M |
| High Estimate | -- | -- | 1.7M | 90.3M |
| Year Ago Sales | -- | -- | -- | 1.7M |
| Sales Growth (year/est) | -- | -- | -- | 5,211.76% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LYTIX.OL | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Related Tickers
PCIB.OL PCI Biotech Holding ASA
1.3150
+1.15%
4FR.F Faron Pharmaceuticals Oy
2.4000
-2.64%
BGBIO.OL BerGenBio ASA
1.7600
-3.19%
ZLNA.OL Zelluna ASA
16.20
-4.71%
1VT.F Viking Therapeutics, Inc.
22.01
+0.85%
CANTA.ST Cantargia AB (publ)
1.5640
-0.13%
FLUO.ST FluoGuide A/S
39.50
+0.25%
VRCA Verrica Pharmaceuticals Inc.
0.4587
-1.99%
VYNE VYNE Therapeutics Inc.
1.8400
-1.08%
IBO Impact BioMedical Inc.
0.4258
+0.34%